ADC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
ADC
Jul 26, 2024, 00:18 |
Blog
Sara Tolaney on novel therapies for young women with breast cancer at Young Women's Forum
Young Women's Forum shared on X: "Honored to have Sara Tolaney, Chief of Breast Oncology…
Jul 11, 2024, 13:45 |
Insight
Winette Van Der Graaf: Grateful to chair the board of EORTC for another 2 years
Winette Van Der Graaf shared a post by EORTC on X, adding: “Grateful to chair…
Jun 25, 2024, 16:01 |
Insight
Paolo Tarantino: Phase 1 trial of the HER2 topo1 ADC SHR-A1811 out in Journal of Clinical Oncology
Paolo Tarantino shared on X: . "Phase 1 trial of the HER2 topo1 ADC SHR-A1811…
Jun 9, 2024, 15:06 |
Blog
Felipe Couñago: Our study on ADC as an early prognostic marker has been accepted in ASTRO
Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a post on X: "Our study…
Jun 8, 2024, 05:20 |
Insight
Mohammad Jad Moussa: ASCO24 Proceedings - GTA as a Nephron-Sparing 'Bridging' Strategy
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared a post…
Jun 5, 2024, 09:52 |
Insight
The future of ADCs treatment in cancer - Springer Medicine
Springer Medicine recently shared a post on X: "Dr. Dieras shares her hopes for the…
Jun 1, 2024, 11:46 |
Blog
Phase 2 study OptiTROP-Lung01 had promising results in patients with advanced NSCLC - LUNGevity Foundation
LUNGevity Foundation shared on X/Twitter: "Phase 2 study (OptiTROP-Lung01) had promising results in patients with advanced…
May 28, 2024, 14:25 |
Insight
Luis E. Raez: Sometimes new agents don't have a better OS but they provide benefits
Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post by Stephen Liu on…
May 28, 2024, 08:21 |
Blog
Antonio Passaro's top 10 selection with explanation, among the lung cancer abstracts from ASCO24
Antonio Passaro, shared a post on X: ''ASCO24 is ready to start soon! Here, my top…
May 22, 2024, 04:28 |
Blog
Michael Torres: This review is getting a lot of play
Michael Torres, PhD in Cancer Bio at UT Southwestern News, shared on X/Twitter: "Homogeneous multi-payload…
Apr 29, 2024, 10:43 |
Blog
Stephanie Graff: Getting excited for ASCO24. Abstract titles are officially out
Stephanie Graff shared a post on X: "Getting excited for ASCO24 Annual Meeting. Abstract titles are…
Apr 27, 2024, 14:44 |
Insight
Aruni Ghose: Our review delves into the progress across urological malignancies and discusses future directions in ADC development
Aruni Ghose, Internal Medicine Resident at Barts Health NHS Trust, shared a post on LinkedIn:…
Apr 14, 2024, 02:34 |
Drugs
Joe Daccache: The realm of ADCs and their potential in oncology
Joe Daccache, Engagement Manager at DeciBio, shared a post on LinkedIn: "As we witness remarkable…
Apr 11, 2024, 13:38 |
Blog
Paolo Tarantino: Wonderful and fun discussions on ADCs at AACR24 with Helena Yu and Petros Grivas
Paolo Tarantino, Advanced Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute, shared a…
Apr 9, 2024, 12:53 |
Blog
Christiana Bardon: The AACR industry partnering event was a tremendous success
Christiana Bardon, Co-Managing Partner at MPM BioImpact, shared on their LinkedIn: ''The American Association for…
Mar 21, 2024, 17:13 |
Blog
Raffaele Colombo: It was such an honor and a pleasure to open the DAVA Oncology Think Tank on Antibody Drug Conjugates and Bispecifics meeting in Victoria
Raffaele Colombo, Principal Scientist and Group Lead, Medicinal Chemistry at Zymeworks Inc., recently posted on…
Mar 5, 2024, 14:37 |
Blog
Paolo Tarantino: Interesting read on many recent deals in the ADC field
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Jan 24, 2024, 22:11 |
Insight
Jean-Charles Soria: Delving into the future of cancer treatment with new ADC formats
Jean-Charles Soria, Senior Vice President of Oncology within Global Development at Amgen, posted the following…
Nov 25, 2023, 17:59 |
Drugs
Andrew Pannu: The ADC space is blowing up
Andrew Pannu posted on LinkedIn: "The ADC space is blowing up: • More than $125B in…
Nov 11, 2023, 17:08 |
Blog
Katsuaki Maehara: Great article about ADCs by Paolo Tarantino
Katsuaki Maehara, Director of Medical Education Colleagues, recently shared the following on X/Twitter: "Great article…
Nov 4, 2023, 00:25 |
Insight
María Natalia Gandur Quiroga: After a successful ESMO 23, ADC continues to shine
María Natalia Gandur Quiroga shared a post on X/Twitter: “After a successful ESMO 23, ADC…
Oct 16, 2023, 23:06 |
Opinion
Paolo Tarantino: Greatly enjoyed contributing to the ADC session at Targets23!
Paolo Tarantino, MD and Researcher at the European Institute of Oncology and Clinical Research Fellow at…
All:
22
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube